Literature DB >> 12648462

EGF receptor ligands.

Raymond C Harris1, Eunkyung Chung, Robert J Coffey.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12648462     DOI： 10.1016/s0014-4827(02)00105-2

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN： 0014-4827            Impact factor:   3.905


× No keyword cloud information.
  238 in total

1.  Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context.

Authors:  Elizabeth J Joslin; Harish Shankaran; Lee K Opresko; Nikki Bollinger; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biosyst       Date:  2010-05-10

2.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

3.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

4.  Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.

Authors:  Angelica Belo; Kunrong Cheng; Ahmed Chahdi; Jasleen Shant; Guofeng Xie; Sandeep Khurana; Jean-Pierre Raufman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-27       Impact factor: 4.052

5.  Amphiregulin exosomes increase cancer cell invasion.

Authors:  James N Higginbotham; Michelle Demory Beckler; Jonathan D Gephart; Jeffrey L Franklin; Galina Bogatcheva; Gert-Jan Kremers; David W Piston; Gregory D Ayers; Russell E McConnell; Matthew J Tyska; Robert J Coffey
Journal:  Curr Biol       Date:  2011-04-21       Impact factor: 10.834

6.  Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.

Authors:  Goro Oshima; Johan Wennerberg; Takashi Yamatodani; Elisabeth Kjellén; Hiroyuki Mineta; Anders Johnsson; Lars Ekblad
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-23       Impact factor: 4.553

7.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Authors:  Nagaraj S Nagathihalli; Yugandhar Beesetty; Wooin Lee; M Kay Washington; Xi Chen; A Craig Lockhart; Nipun B Merchant
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

8.  A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies.

Authors:  Michihiro Yoshida; Takaya Shimura; Mikinori Sato; Masahide Ebi; Takahiro Nakazawa; Hiromitsu Takeyama; Takashi Joh
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-26       Impact factor: 4.553

Review 9.  Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma.

Authors:  Ana Markovic; Christine H Chung
Journal:  Expert Rev Anticancer Ther       Date:  2012-09       Impact factor: 4.512

Review 10.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.